Join to View Full Profile
1400 S Orange AveOrlando, FL 32806
Phone+1 321-843-2100
Fax+1 321-842-3498
Dr. Young is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Young is an oncology specialist based in Orlando, FL, with subspecialties in genitourinary and hematologic oncology. She completed her fellowship in Hematology and Medical Oncology at Orlando Health in 2022 and her residency in Internal Medicine at Sidney Kimmel Medical College at Thomas Jefferson University/TJUH in 2019. Dr. Young graduated from Virginia Tech Carilion School of Medicine in 2016. Her research has been published in several scientific journals, including an article on Anaplastic Large Cell Lymphoma in Cureus and studies on prostate and renal cancer models cited multiple times in other publications.
Education & Training
Orlando HealthFellowship, Hematology and Medical Oncology, 2019 - 2022
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2016 - 2019
Virginia Tech Carilion School of MedicineClass of 2016
Certifications & Licensure
FL State Medical License 2022 - 2027
PA State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Partial Response to Small Molecule Inhibition in a Case of Anaplastic Large Cell Lymphoma.Sarah Young, Amirah Kuzu, Mike Magill, Julio Hajdenberg
Cureus. 2022-03-01 - 23 citationsCasein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.Robin T. Varghese, Sarah Young, Lily Pham, Yanping Liang, Kevin J. Pridham
Scientific Reports. 2018-09-11 - 15 citationsSpheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.Matthias Saar, Hongjuan Zhao, Rosalie Nolley, Sarah R. Young, Ilsa Coleman
Cancer Letters. 2014-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
